Cosmos Health Inc. (COSM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$15.33M
Year ended 2025-12-31
-$16.94M
Trailing 12 months to 2026-06-30
$3.11M2018-12-31: -$1.18M2019-12-31: $138.8K2020-12-31: $3.11M2021-12-31: -$4.08M2022-12-31: -$7.29M2023-12-31: -$21.22M2024-12-31: -$14.30M2025-12-31: -$15.33M-$15.33M
2018-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$15.33Mn/m2026-04-15, From 2025-01-01
2024-12-31-$14.30Mn/m2026-04-15, From 2024-01-01
2023-12-31-$21.22Mn/m2025-04-15, From 2023-01-01
2022-12-31-$7.29Mn/m2024-08-05, From 2022-01-01
2021-12-31-$4.08Mn/m2023-04-12, From 2021-01-01
2020-12-31$3.11Mn/m2022-12-16, From 2020-01-01
2019-12-31$138.8Kn/m2021-04-15, From 2019-01-01
2018-12-31-$1.18Mn/a2020-04-14, From 2018-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Cosmos Health Inc. (COSM)2025-12-31-$15.33Mn/m
DataMeds AI, Inc. (MEDS)2025-12-31-$90.54Mn/m
Stemtech Corp (STEK)2025-12-31-$2.54Mn/m
Nu Skin Enterprises, Inc. (NUS)2025-12-31$118.02Mn/m
Herbalife Ltd. (HLF)2025-12-31$602.20M+18.7%
Cardinal Health Inc (CAH)2026-06-30$3.57B+16.4%
Cencora, Inc. (COR)2025-09-30$3.68B+12.6%
McKesson Corp (MCK)2026-03-31$6.94B+37.2%

Compare COSM, MEDS, STEK, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗